
Retatrutide · 10 mg
"Your metabolic prime, reclaimed."
Retatrutide (LY3437943) is a highly potent, novel triple agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. This synergistic tri-agonist mechanism is being rigorously studied for its unprecedented effects on metabolic regulation, energy expenditure, and comprehensive weight management in preclinical models.
Research Focus Areas
Our pre-filled pens eliminate the steps that stand between you and your protocol. No bacteriostatic water, no syringes, no reconstitution calculations. Just consistent, precise delivery from day one.

Every BioPepTech pen is presented in our handcrafted signature case, designed to protect it during travel and reflect the precision inside. A protocol worth doing is worth keeping well.
Message us on WhatsApp. Our team will confirm availability, dosing guidance, and arrange Bali delivery.